HomeNewsBusinessStocksBuy Edelweiss Fin, NBCC, Marksans Pharma: Pankaj Jain
Trending Topics
Sensex Live
Capillary Technologies IPO
Tenneco Clean Air India IPO
Groww IPO
Gold Rate

Buy Edelweiss Fin, NBCC, Marksans Pharma: Pankaj Jain

Pankaj Jain of Sunteck Wealthmax is of the view that one can buy Sona Koyo Steering Systems for a target of Rs 51.55 and Marksans Pharma for a target of Rs 54.75.

September 04, 2014 / 12:13 IST
Story continues below Advertisement
Remove Ad

Your browser doesn't support HTML5 video.

In CNBC-TV18's popular show Bull's Eye, Pankaj Jain of Sunteck Wealthmax shares his trading strategies for the day.

One can buy Edelweiss Financial Services for a target price of Rs 57.75.

Story continues below Advertisement
Remove Ad

One can buy National Buildings Construction Corporation (NBCC) for a target price of Rs 496 and keep a stoploss at Rs 458.

One can buy Marksans Pharma for a target price of Rs 54.75 and keep a stoploss at Rs 49.40.

Follow Us On: Facebook twitter instagram linkedin telegram youtube
News
Business New Market New Stocks Income Tax Calculator Election Schedule 2024 India News Economy Mutual Funds Personal Finance IPO News Startups New USA Elections New
Features
Gold Rate Today Silver Rate Today Trending News Startups New National News MC Videos MC You Tube
Tools
SIP Calculator 2 SIP Calculator 3 SIP Calculator 1 New SIP Calculator 4
Specials
PowerYourTrade Master Your Money Game Changers
Network 18 Sites
News18 Firstpost CNN News18 CNBC TV18 Forbes History TV18
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker Fixed Deposits Fixed Deposit Comparison Fixed Income Account Aggregator
Quick Links
About Us New Contact Us Advisory Alert New Advertise with Us New Disclaimer Privacy Policy Cookie Policy Terms & Conditions Careers Financial Terms (Glossary) Analytical & Information Tool New
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.